Section Arrow
LYEL.NASDAQ
- Lyell Immunopharma Inc
Quotes are at least 15-min delayed:2026/01/01 21:43 EST
Regular Hours
Last
 30.78
-0.81 (-2.56%)
Day High 
32.275 
Prev. Close
31.59 
1-M High
45 
Volume 
193.59K 
Bid
30
Ask
32.9
Day Low
30.01 
Open
31.28 
1-M Low
20.59 
Market Cap 
671.10M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 34.65 
20-SMA 31.47 
50-SMA 23.56 
52-W High 45 
52-W Low 7.65 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-22.75/-9.78
Enterprise Value
722.09M
Balance Sheet
Book Value Per Share
15.49
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
61.00K
Operating Revenue Per Share
2.28
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MREOMereo BioPharma Group plc0.4167+0.0462+12.47%-- 
OTLKOutlook Therapeutics1.58-0.285-15.28%0.58PE
VNDAVanda Pharmaceuticals8.82+1.79+25.46%126.25PE
SLSSELLAS Life Sciences Group3.77+0.46+13.90%-- 
FBLGFibroBiologics0.2249-0.017-7.03%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.